Author details

Full Name

David G Cox

Affiliation

ORCID

Career Start Year

2001

Papers

118

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36003767	Outcome of lung oligometastatic patients treated with stereotactic body irradiation.	Frontiers in Oncology	2022
34622145	Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes.	J Transl Genet Genom	2021
32612272	Analysis of the StoRM cohort reveals physical activity to be associated with survival in metastatic breast cancer.	Scientific Reports	2020
32064237	Genetically Determined Height and Risk of Non-hodgkin Lymphoma.	Front Oncol	2020
32881892	Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma.	PLoS One	2020
31407831	Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.	Genet Epidemiol	2019
28004270	Determinants of folate and vitamin B12 plasma levels in the French E3N-EPIC cohort.	European Journal of Nutrition	2018
29933179	Transmission of breast cancer polygenic risk based on single nucleotide polymorphisms.	Breast	2018
29915430	A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.	Nat Genet	2018
30093639	Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility.	Nat Commun	2018
29326028	A new era for treatment development in HER2-positive breast cancer.	Lancet Oncology, The	2018
29156890	Why the results of adjuvant pertuzumab in HER2-positive early breast cancer has been received as a mitigate success?	Chinese Clinical Oncology	2018
29735552	HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.	Cancer Res	2018
28241208	Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.	JAMA Oncol	2017
28624696	Superimposable outcomes for sequential and concomitant administration of adjuvant trastuzumab inÂ HER2-positive breast cancer: Results from the SIGNAL/PHARE prospective cohort.	European Journal of Cancer	2017
28830573	Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.	Breast Cancer Research	2017
28781888	A GWAS in uveal melanoma identifies risk polymorphisms in the <i>CLPTM1L</i> locus.	NPJ Genom Med	2017
29059683	Association analysis identifies 65 new breast cancer risk loci.	Nature	2017
29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Nat Genet	2017
28649644	Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort.	NPJ Breast Cancer	2017
28394329	A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.	Nature Medicine	2017
29214033	Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma.	Lupus Sci Med	2017
27905104	Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort.	Int J Cancer	2017
28029350	[Erratum to: "Breast cancer screening: On our way to the future" [Bull. Cancer 103 (2016) 753-763]].		2016
27008888	Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes.	Hum Mol Genet	2016
27228256	Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.	JAMA Oncol	2016
27473920	[Breast cancer screening: On our way to the future].		2016
26850968	Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control Population.		2016
27764800	GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.	Oncotarget	2016
26406445	Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2.	PLoS ONE	2015
25925750	An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.	Breast Cancer Res	2015
25688114	Therogenetics: transferring GWAS technology to the clinic.	Mutagenesis	2015
25688109	Les Entretiens Jacques Cartier Symposium 4--targeted cancer therapies: stakes and prospects for patients.	Mutagenesis	2015
26307654	Genome-wide association study of prostate cancer-specific survival.	Cancer Epidemiol Biomarkers Prev	2015
26214589	Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.	Nat Genet	2015
26460308	Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.	J Clin Oncol	2015
24884505	Mitochondrial haplogroups modify the effect of black carbon on age-related cognitive impairment.	Environ Health	2014
25261932	Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.	Nat Genet	2014
24437375	Factors associated with oxidative stress and cancer risk in the Breast and Prostate Cancer Cohort Consortium.	Free Radical Research	2014
24336192	Age at cancer onset in germline TP53 mutation carriers: association with polymorphisms in predicted G-quadruplex structures.	Carcinogenesis	2014
24501324	Cost-effectiveness of a genetic test for breast cancer risk--letter.	Cancer Prevention Research	2014
24590452	Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort.	Int J Cancer	2014
24718872	Dietary fat intake and development of specific breast cancer subtypes.	Journal of the National Cancer Institute	2014
24523857	A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer.	PLoS One	2014
24521025	Genome-wide association studies and the clinic: a focus on breast cancer.	Biomarkers in Medicine	2014
24895409	Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women.	Hum Mol Genet	2014
25085564	Influence of multiple APOE genetic variants on cognitive function in a cohort of older men - results from the Normative Aging Study.	BMC Psychiatry	2014
23065704	A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.	Hum Mol Genet	2013
24099317	Polymorphisms in xenobiotic metabolizing genes, intakes of heterocyclic amines and red meat, and postmenopausal breast cancer.	Nutr Cancer	2013
23836507	Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinoma.	Genes Chromosomes and Cancer	2013